Clinical characterization and diagnosis of cystic fibrosis through exome sequencing in Chinese infants with Bartter-syndrome-like hypokalemia alkalosis
Cystic fibrosis (CF) is a fatal autosomal-recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. CF is characterized by recurrent pulmonary infection with obstructive pulmonary disease. CF is common in the Caucasian population but is rare in the Chinese population. The symptoms of early-stage CF are often untypical and may sometimes manifest as Bartter syndrome (BS)-like hypokalemic alkalosis. Therefore, the ability of doctors to differentiate CF from BS-like hypokalemic alkalosis in Chinese infants is a great challenge in the timely and accurate diagnosis of CF. In China, sporadic CF has not been diagnosed in children younger than three years of age to date. Three infants, who were initially admitted to our hospital over the period of June 2013 to September 2014 with BS-like hypokalemic alkalosis, were diagnosed with CF through exome sequencing and sweat chloride measurement. The compound heterozygous mutations of the CFTR gene were detected in two infants, and a homozygous missense mutation was found in one infant. Among the six identified mutations, two are novel point mutations (c.1526G>C and c.3062C>T) that are possibly pathogenic. The three infants are the youngest Chinese patients to have been diagnosed with sporadic CF at a very early stage. Follow-up examination showed that all of the cases remained symptom-free after early intervention, indicating the potential benefit of very early diagnosis and timely intervention in children with CF. Our results demonstrate the necessity of distinguishing CF from BS in Chinese infants with hypokalemic alkalosis and the significant diagnostic value of powerful exome sequencing for rare genetic diseases. Furthermore, our findings expand the CFTR mutation spectrum associated with CF.
Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al.. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245(4922): 1066–1073 https://doi.org/10.1126/science.2475911
pmid: 2475911
2
Dawson KP, Frossard PM. The geographic distribution of cystic fibrosis mutations gives clues about population origins. Eur J Pediatr 2000; 159(7): 496–499 https://doi.org/10.1007/s004310051317
pmid: 10923221
3
Yamashiro Y, Shimizu T, Oguchi S, Shioya T, Nagata S, Ohtsuka Y. The estimated incidence of cystic fibrosis in Japan. J Pediatr Gastroenterol Nutr 1997; 24(5): 544–547 https://doi.org/10.1097/00005176-199705000-00010
pmid: 9161949
4
Shen Y, Liu J, Zhong L, Mogayzel PJ Jr, Zeitlin PL, Sosnay PR, Zhao S. Clinical phenotypes and genotypic spectrum of cystic fibrosis in Chinese children. J Pediatr 2016; 171:269–276.e1 https://doi.org/10.1016/j.jpeds.2015.12.025
5
Xu BP, Wang H, Zhao YH, Liu J, Yao Y, Feng XL, Shen KL. Molecular diagnosis of two Chinese cystic fibrosis children and literature review. Chin J Pediatr (Zhonghua Er Ke Za Zhi) 2016; 54(5): 344–348 (in Chinese)
pmid: 27143075
6
Xie Y, Huang X, Liang Y, Xu L, Pei Y, Cheng Y, Zhang L, Tang W. A new compound heterozygous CFTR mutation in a Chinese family with cystic fibrosis. Clin Respir J2017; 11(6):696–702 https://doi.org/10.1111/crj.12401
pmid: 26471113
7
Wang PL, Jing JY, Shen HH. Retrospective analysis on twenty Chinese cases of cystic fibrosis. Chin J Pediatr (Zhonghua Er Ke Za Zhi) 2008; 46(8): 634–636 (in Chinese)
pmid: 19099843
8
Macek M Jr, Mercier B, Macková A, Miller PW, Hamosh A, Férec C, Cutting GR. Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations and novel Asian mutations in the CFTR gene. Hum Mutat 1997; 9(2): 36–47 https://doi.org/10.1002/(SICI)1098-1004(1997)9:2<136::AID-HUMU6>3.0.CO;2-7
pmid: 9067754
9
Chen HJ, Lin SP, Lee HC, Chen CP, Chiu NC, Hung HY, Chern SR, Chuang CK. Cystic fibrosis with homozygous R553X mutation in a Taiwanese child. J Hum Genet 2005; 50(12): 674–678 https://doi.org/10.1007/s10038-005-0309-x
pmid: 16283068
10
Wagner JA, Vassilakis A, Yee K, Li M, Hurlock G, Krouse ME, Moss RB, Wine JJ. Two novel mutations in a cystic fibrosis patient of Chinese origin. Hum Genet 1999; 104(6): 511–515 https://doi.org/10.1007/s004390050996
pmid: 10453741
11
Tian X, Liu Y, Yang J, Wang H, Liu T, Xu W, Li X, Zhu Y, Xu KF, Zhang X. p.G970D is the most frequent CFTR mutation in Chinese patients with cystic fibrosis. Hum Genome Var 2016; 3: 15063 https://doi.org/10.1038/hgv.2015.63
pmid: 27081564
12
Liu JR, Peng Y, Zhao YH, Wang W, Guo Y, He JX, Zhao SY, Jiang ZF. Clinical manifestations and gene analysis of 2 Chinese children with cystic fibrosis. Chin J Pediatr (Zhonghua Er Ke Za Zhi) 2012; 50(11): 829–833 (in Chinese)
pmid: 23302613
13
Li N, Pei P, Bu DF, He B, Wang GF. A novel CFTR mutation found in a Chinese patient with cystic fibrosis. Chin Med J (Engl) 2006; 119(2): 103–109
pmid: 16454991
14
Li N, He B, Wang GF, Tang XY. A case report of cystic fibrosis and review of 16 cases of cystic fibrosis in Chinese patients. Chin J Tuberc Respir Dis (Zhonghua Jie He He Hu Xi Za Zhi) 2003; 26(9): 559–562 (in Chinese)
pmid: 14521762
15
Li HX, Mao WJ, Chen JY, Zheng MF, Ye SG, He YJ, Liu F. Analysis of curative effect of pulmonary lobectomy on atelectasis after lung transplantation. Organ Transplant (Qi Guan Yi Zhi), 2014. 5(1): 24–27, 31 (in Chinese)
16
Liu Y, Wang L, Tian X, Xu KF, Xu W, Li X, Yue C, Zhang P, Xiao Y, Zhang X. Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients. Respirology 2015; 20(2): 312–318 https://doi.org/10.1111/resp.12452
pmid: 25580864
17
Cremonesi L, Ferrari M, Belloni E, Magnani C, Seia M, Ronchetto P, Rady M, Russo MP, Romeo G, Devoto M. Four new mutations of the CFTR gene (541delC, R347H, R352Q, E585X) detected by DGGE analysis in Italian CF patients, associated with different clinical phenotypes. Hum Mutat 1992; 1(4): 314–319 https://doi.org/10.1002/humu.1380010409
pmid: 1284538
18
Lee KH, Ryu JK, Yoon WJ, Lee JK, Kim YT, Yoon YB. Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci 2005; 50(10): 1852–1856 https://doi.org/10.1007/s10620-005-2950-9
pmid: 16187186
19
Sheppard DN, Travis SM, Ishihara H, Welsh MJ. Contribution of proline residues in the membrane-spanning domains of cystic fibrosis transmembrane conductance regulator to chloride channel function. J Biol Chem 1996; 271(25): 14995–15001 https://doi.org/10.1074/jbc.271.25.14995
pmid: 8663008
Kessler WR, Andersen DH. Heat prostration in fibrocystic disease of the pancreas and other conditions. Pediatrics 1951; 8(5): 648–656
pmid: 14891321
22
Scurati-Manzoni E, Fossali EF, Agostoni C, Riva E, Simonetti GD, Zanolari-Calderari M, Bianchetti MG, Lava SA. Electrolyte abnormalities in cystic fibrosis: systematic review of the literature. Pediatr Nephrol 2014; 29(6): 1015–1023 https://doi.org/10.1007/s00467-013-2712-4
pmid: 24326787
Mei-Zahav M, Durie P, Zielenski J, Solomon M, Tullis E, Tsui LC, Corey M. The prevalence and clinical characteristics of cystic fibrosis in South Asian Canadian immigrants. Arch Dis Child 2005; 90(7): 675–679 https://doi.org/10.1136/adc.2003.042614
pmid: 15970608
25
Callaghan BD, Hoo AF, Dinwiddie R, Balfour-Lynn IM, Carr SB. Growth and lung function in Asian patients with cystic fibrosis. Arch Dis Child 2005; 90(10): 1029–1032 https://doi.org/10.1136/adc.2004.067264
pmid: 16177157
26
Mattar AC, Leone C, Rodrigues JC, Adde FV. Sweat conductivity: an accurate diagnostic test for cystic fibrosis? J Cyst Fibros 2014; 13(5): 528–533 https://doi.org/10.1016/j.jcf.2014.01.002
pmid: 24485874
27
Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR. Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. J Pediatr 2017; 181S: S4–S15.e1 https://doi.org/10.1016/j.jpeds.2016.09.064
pmid: 28129811